Browse All

Current Filters

CLEAR FILTER x

TITLE

Title
    Author Last Name
      Session Name
        Topic
          Program Number
            Author Institution

              P2B001 (low dose combination of extended-release pramipexole and rasagiline) versus titrated extended-release pramipexole in the management of early Parkinson’s disease: Exploratory findings from a randomized, controlled trial

              Author:Elmer, Lawrence   Litman, Pninit   Friedman, Hadas   Fitzer-Attas, Cheryl   Oren, Sheila   

              Session Name:S32: Movement Disorders: Trials  

              Topic:Movement Disorders  

              Program Number:S32.010  

              Author Institution:University of Toledo College of Medicine and Life Sciences, Toledo, OH  Pharma Two B, Rehovot, Israel  Pharma Two B, Jersey City, NJ  

              P2B001 significantly reduced risk of daytime sleepiness: results from a randomized controlled phase 3 trial with active pramipexole arm in early Parkinson’s disease (PD)

              Author:Kreitzman, David   Litman, Pninit   Friedman, Hadas   Oren, Sheila   Fitzer-Attas, Cheryl   

              Session Name:P2: Movement Disorders: Clinical Trials in Parkinson's Disease 2  

              Topic:Movement Disorders  

              Program Number:P2.001  

              Author Institution:Parkinson's Disease and Movement Disorders Center of Long Island, Commack, NY  Pharma Two B, Rehovot, Israel